Funder
Instituto de Salud Carlos III
Ministerio de Economía y Competitividad
Consejería de Educación, Juventud y Deporte, Comunidad de Madrid
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. Cancer statistics, 2019;RL Siegel;CA Cancer J Clin,2019
2. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease;NK Janzen;Urol Clin North Am,2003
3. Adjuvant therapy in renal cell carcinoma-past, present, and future;T Janowitz;Semin Oncol,2013
4. Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial;M Staehler;Ann Oncol,2018
5. What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial;NJ Lawrence;Kidney Cancer,2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献